Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$212.02 - $267.71 $99,649 - $125,823
470 Added 57.04%
1,294 $279,000
Q4 2023

Feb 09, 2024

BUY
$222.59 - $267.94 $183,414 - $220,782
824 New
824 $213,000
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $293,416 - $339,051
1,066 New
1,066 $304,000
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $1.2 Million - $1.45 Million
4,737 New
4,737 $1.31 Million
Q2 2022

Aug 12, 2022

BUY
$187.54 - $223.02 $597,502 - $710,541
3,186 New
3,186 $650,000
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $459,483 - $590,504
-2,052 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $546,453 - $712,635
-1,931 Reduced 48.48%
2,052 $581,000
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $1.03 Million - $1.65 Million
3,983 New
3,983 $1.38 Million
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $329,638 - $380,608
-1,245 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $322,031 - $426,474
1,245 New
1,245 $333,000
Q1 2020

May 13, 2020

SELL
$268.85 - $341.04 $193,572 - $245,548
-720 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $189,251 - $261,500
-860 Reduced 54.43%
720 $214,000
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $343,555 - $385,330
1,580 New
1,580 $368,000
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $203,720 - $224,557
-929 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$216.71 - $338.96 $201,323 - $314,893
929 New
929 $220,000
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $704,424 - $921,192
-2,400 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $618,048 - $736,584
2,400 New
2,400 $697,000
Q1 2018

May 14, 2018

SELL
$260.13 - $367.91 $416,208 - $588,656
-1,600 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$307.64 - $344.58 $135,361 - $151,615
440 Added 37.93%
1,600 $510,000
Q3 2017

Nov 08, 2017

BUY
$281.15 - $329.69 $106,836 - $125,282
380 Added 48.72%
1,160 $363,000
Q2 2017

Aug 17, 2017

BUY
N/A
780
780 $212,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.